Wellbutrin SR vs XL: Key Formulation Differences
The primary difference between Wellbutrin SR (Sustained Release) and XL (Extended Release) is the dosing frequency: SR requires twice-daily administration (typically 150 mg twice daily for a total of 300 mg/day), while XL is dosed once daily in the morning (typically 300 mg once daily). 1
Pharmacokinetic Differences
- SR formulation reaches peak concentration (Tmax) at approximately 3 hours, while XL has a prolonged absorption with Tmax at approximately 5 hours 2
- Despite different absorption profiles, all three bupropion formulations (IR, SR, and XL) are bioequivalent in terms of systemic exposure to bupropion and its active metabolites 3, 2
- The extended absorption of XL allows for once-daily dosing convenience compared to SR's twice-daily requirement 2
Dosing Schedules and Administration
SR (Sustained Release) Formulation:
- Start with 150 mg once daily for 3 days, then increase to 150 mg twice daily (300 mg total) 1
- The second dose must be administered before 3 PM to minimize insomnia risk 1
- Maximum dose is 400 mg per day 1
XL (Extended Release) Formulation:
- Initial dose of 150 mg once daily, with maintenance dose of 150-300 mg once daily 1
- Administered in the morning as a single dose 1
- Maximum dose is 450 mg per day 1
Clinical Efficacy Considerations
- Both formulations demonstrate comparable efficacy for major depressive disorder, with SR showing consistent effectiveness across multiple trials 3
- XL established efficacy in two of six well-designed placebo-controlled studies for primary outcomes, though it demonstrated efficacy in secondary outcomes in five studies 3
- SR was as effective as SSRIs with advantages of less somnolence and sexual dysfunction 3
Practical Clinical Decision-Making
Choose SR formulation when:
- Patients require more flexible dosing due to side effects or need dose adjustments for hepatic or renal impairment 1
- Patients can reliably take medications twice daily
- Lower maximum daily doses are needed (400 mg vs 450 mg for XL)
Choose XL formulation when:
- Once-daily dosing improves medication adherence 3, 4
- Patients prefer simplified medication regimens
- Higher maximum doses may be needed (up to 450 mg daily) 1
Critical Safety Monitoring
- Historical bioequivalence issues existed with some generic SR formulations; monitor patients closely when switching between brand and generic or between SR and XL formulations 1
- Both formulations lower seizure threshold and are contraindicated in patients with seizure disorders 1
- For hepatic impairment (moderate to severe), total daily dose should not exceed 150 mg daily regardless of formulation 1
- For renal impairment (moderate to severe), reduce total daily dose by half 1